Robin Sequence and Osteopathia Striata With Cranial Sclerosis (OSCS): A Case Series.

Cleft Palate Craniofac JNov 17, 2025 (epub)

Arhana Chattopadhyay, Liara S Ortiz-Ocasio, Natasha Shur et al.

✦ AI-curated · Sources linked

Case in brief

Two infants presented with Robin sequence (RS) alongside osteopathia striata with cranial sclerosis (OSCS), an uncommon combination. Both underwent mandibular distraction osteogenesis (MDO) for upper airway obstruction. In the infant with more severe OSCS, apneic episodes persisted after MDO and tracheostomy was required. In the other infant, MDO successfully managed the obstruction. The contrasting outcomes suggest that OSCS severity may be relevant when assessing the likely response to MDO in this clinical setting.

What made this case unusual

The two infants had different airway outcomes after MDO: persistent apnea requiring tracheostomy in the infant with more severe OSCS, versus successful obstruction management in the other.

Diagnostic / clinical pearl

In infants with RS and OSCS, consider OSCS severity when assessing airway management and the potential outcome of MDO; persistent apnea may require further intervention.

Source

Published in Cleft Palate Craniofac J. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.